Last update Oct. 28, 2014

Chasteberry

High Risk

Poorly safe. Evaluate carefully. Use safer alternative or interrupt breastfeeding 3 to 7 T ½ (elimination half-lives). Read the Comment.

Ripe fruits are used. It contains heterosidic iridoid, estrogen-like flavonoids, terpenes and linoleic acid.

Although traditionally used as a galactagogue, it contains diterpenes that have a dopamine-like effect which is inhibitory of prolactin release and milk production.

Indications approved by the Commission E of the German Ministry of Health are: Irregularity of menses, pre-menstrual syndrome, mastodinia.

Alternatives

We do not have alternatives for Chasteberry.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Other names

Chasteberry is also known as


Group

Chasteberry belongs to this group or family:

Tradenames

Main tradenames from several countries containing Chasteberry in its composition:

  • Ginevítex™. Contains other elements than Chasteberry in its composition
  • Mastodynon™. Contains other elements than Chasteberry in its composition
  • Mastodynon (Мастодинон)™. Contains other elements than Chasteberry in its composition
  • Pascofemin™. Contains other elements than Chasteberry in its composition

References

  1. Powers CN, Setzer WN. A molecular docking study of phytochemical estrogen mimics from dietary herbal supplements. In Silico Pharmacol. 2015 Mar 22;3:4. Abstract Full text (link to original source) Full text (in our servers)
  2. Eglash A. Treatment of maternal hypergalactia. Breastfeed Med. 2014 Abstract Full text (link to original source) Full text (in our servers)
  3. Sachs HC; Committee On Drugs. The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Pediatrics. 2013 Sep;132(3):e796-809. Abstract Full text (link to original source) Full text (in our servers)
  4. Mortel M, Mehta SD. Systematic review of the efficacy of herbal galactogogues. J Hum Lact. 2013 Abstract
  5. Posadzki P, Watson LK, Ernst E. Adverse effects of herbal medicines: an overview of systematic reviews. Clin Med (Lond). 2013 Abstract Full text (link to original source)
  6. Amir LH, Pirotta MV, Raval M. Breastfeeding--evidence based guidelines for the use of medicines. Aust Fam Physician. 2011 Sep;40(9):684-90. Review. Abstract Full text (link to original source) Full text (in our servers)
  7. WHO. World Health Organization. WHO monographs on selected medicinal plants. Volume 4. WHO monographs. 2009 Full text (link to original source) Full text (in our servers)
  8. Tesch BJ. Herbs commonly used by women: an evidence-based review. Am J Obstet Gynecol. 2003 Abstract
  9. Hardy ML. Herbs of special interest to women. J Am Pharm Assoc (Wash). 2000 Abstract

Total visits

10,265

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2006 of United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM